Roche and Flare Therapeutics are igniting a partnership worth more than $1.8 billion in biobucks with hopes of discovering new cancer drugs.

Scientists studied how the epigenetic landscape influences the binding of pioneer transcription factors, affecting access to DNA.

Transcription factor oligodeoxynucleotide (ODN) decoys are new research tools designed to enhance the study of gene regulation. The approach involves flooding the cells with enough double-stranded ...

A research team introduces a new large-scale study on human transcription factors combining two state-of-the art interactomics methods that allow rapid identification of protein-protein ...

Researchers find ligand that interacts with the transcription factor FOXA1, which is involved in breast and prostate cancers ...

The ABA-induced NAC transcription factor MdNAC1 interacts with a bZIP-type transcription factor to promote anthocyanin synthesis in red-fleshed apples ...